We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iq-ai Limited | LSE:IQAI | London | Ordinary Share | JE00BD4H0R42 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.55 | 1.50 | 1.60 | 1.55 | 1.55 | 1.55 | 197,967 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Florists | 536k | -512k | -0.0028 | -5.54 | 2.83M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/12/2018 19:08 | I am sorry that you feel that my trying to understand 'your stance' makes me not a decent person. You have certainly been very aggressive from the start. A little bit childish too. I say post away. It matters to me little. I am concerned about the investors here and spoiling the board so you might be talking to yourself. | hazl | |
05/12/2018 18:43 | 'Probably short'. Speculation. 'Bad-humour'. Speculation. Here's an idea, instead of pointing out the supposed faults of others, look in a mirror, find your own faults and start to better yourself. That should keep you occupied. | lr2 | |
05/12/2018 18:28 | I see that you have been posting in FDBK for some time which might explain your interest...and perhaps your bad-humour as they don't seem to have done very well lately. | hazl | |
05/12/2018 18:28 | I stand by my calculations. Placing is coming. Time will tell. Produce figures to show otherwise if you can. No idea how to go about short selling. It's not in my nature. Your attitude towards me means I will continue to post here from time to time. Had you been a decent person I would have vanished into the background as I prefer to do after my occasional posts. You better turn your filter on. | lr2 | |
05/12/2018 18:03 | How unnecessary. I find that the way you jumped on my post today,confirms for me that you are probably short. Again your last post is condescending. If I am to listen to someone,I much prefer the attitude of an educated poster like woodcutter who seeks to enlighten, when he unearths something.It was by looking back through numerous posts that I found his helpful post, as the name change and so on made research more complicated. Your smart alec remarks will help me to avoid you in future. | hazl | |
05/12/2018 17:15 | Whether by converting those loan notes and/or going for a placing this company looks as though it requires a large input of cash in the next few months. This is just my opinion. I have given you my calculations regarding the situation as I see it. You are welcome to refute it but please put some figures to your reasoning so that I may see whether you have a valid approach to the problem or not. Looking forward is always some form of speculation and my calculations are no less valid than a lot of your short happy-clappy posts of late. P.S. South Koreans suffer kidney stones because they have a high salt intake and don't have enough lemon juice in their diets. The same can be said for most Asian communities, especially China. | lr2 | |
05/12/2018 17:11 | I am not in the business of being upbeat about a stock if it doesn't warrant it and sometimes it takes a while to unearth every bit of relevant detail, especially in past history. I will reserve judgement for now; this stock seems to have a renewed following as it's international presence has grown. We'll see. | hazl | |
05/12/2018 17:04 | That's Speculation.With reference to the loan notes they are not due until 2020 I believe. I will be interested to see if they have the FDA approval and products that are desired. | hazl | |
05/12/2018 16:54 | I think you may be correct that Brown has some outstanding loan notes but not enough to keep the company afloat for more than a few more months if he converts them. Besides, he is closing in on a 30% shareholding here which would mean him putting in a bid for the whole company if it is crossed. I doubt very much if he is in a position to acquire the company lock, stock and barrel. Also, would you want to be a minor shareholder in a non-quoted private company if he does? | lr2 | |
05/12/2018 16:47 | Ah our posts were in short succession. | hazl | |
05/12/2018 16:45 | Fair enough. I thought that Trevor Brown had some Convertible loan notes so I guess it's to do with that thinking about it. I was a bit disappointed when I first saw them. | hazl | |
05/12/2018 16:44 | Here's my original summer posting suggesting the need for a placing early next year. Please critique my reasoning. If you do a good job of it, who knows, you just might convince me to buy in here... although for that to happen you would have to do a very good job. ____________________ Good morning Shan & Draft, Draft, as per your post, I am not forgetting Imaging Biometrics, it's just that I am not that interested in them as my main focus is on TexRAD at present. However, if you could supply me with IB's income and expenditure figures over the past 2-3 years I will endeavour to take a closer look. Shan, I am currently only invested in Feedback. I have trust issues with one of the board members of Flying Brands which is why I was asking the posters here as to how they were expecting to get FDA approval for the Stone Checker product when the TexRAD software analytics that is core to its usage has not yet gone through the FDA approval process. You all seem quite happy that this isn't going to be a problem but didn't elucidate as to why that was the case other than the company was working closely with the FDA. I decided not to push the matter further. I note however Shan that you seem to think Feedback need more money (almost certainly correct) whereas Flying Brands are 'fully funded' (almost certainly incorrect). I will attempt to demonstrate why I believe you are incorrect regarding Flying Brands. In the company's half year report the cash position as at 30th June was £5,000. The company then raised via a placing in mid-July a sum of £500,000 to keep the lights on. This exercise cost the company £84,000 leaving FBDU with a sum of £416,000. It planned to spend the money as follows: A PACS compliant software plug in for Stone Checker - £80,463. Imaging Biometrics – cash for operational expenses - £60,000. FDA fees for Stone Checker - £48,161. COO's wages - £110,000. Payment of other wages, legal fees, accountancy fees, UKLA and LSE fees, printing costs, consultancy fees, Stone Checker software trials, developing improved products - £200,000. That's a total planned expenditure of £498,624. Now here's the crux for me. In the last 6 months the company lost before tax £371,000. That's a loss of £61,833 per month. So, with £416,000 raised that might keep the lights on another 6-7 months or just under 6 months if you add in the new COO's wages. Look at what they raised, and look at the proposed expenditure. How much of it benefits and pushes the company forward and how much of it benefits the people within the company? So, FBDU had next to no cash at the end of June and the £416,000 they received from the placing will likely last them around 6 months. Shan, I don't view this company as 'fully funded' like you say. In fact, unless Draft can show me immediate exceptional profits arising from IB, I would anticipate your board going back to the market for more cash around Christmas / New Year. ____________________ | lr2 | |
05/12/2018 16:24 | Do you want me to dig out my original calculations so that you can critique them? I don't see myself as a scaremonger as I would have posted here constantly if I were. | lr2 | |
05/12/2018 16:22 | ALSO interesting that these are your only two posts on this thread. | hazl | |
05/12/2018 16:20 | Typical scare-mongering perhaps L2? I have seen no indication of that. imo | hazl | |
05/12/2018 16:03 | Perhaps a little early for forward selling. My calculations indicated a placing likeliest in January or, at latest, February. | lr2 | |
05/12/2018 16:00 | I wouldn't mind as I'm yet to dip a toe in here and would like to but wouldn't there be more volume and evidence of forward selling if that was the case? | flashheart | |
05/12/2018 15:55 | Placing perhaps? Calculated it earlier this year. | lr2 | |
05/12/2018 15:47 | I believe we are hoping for some sort of news before the end of the month? FDA Approval perhaps? Read it somewhere. IMO | hazl | |
05/12/2018 09:36 | The international aspect is the draw here I think. I wonder why South Korea have such a high incidence of kidney-stones? Must be a reason I guess. | hazl | |
03/12/2018 13:20 | they have some pretty high calibre talks too in that institute where IQAI spoke last week....link produced by GED5. | hazl | |
03/12/2018 13:14 | Slight consolidation understandable....lo IMO | hazl | |
01/12/2018 10:04 | some might find this blog interesting........ | hazl | |
30/11/2018 17:05 | Rather a lot of shares in private hands doesn't leave much for the rest of us. | hazl |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions